Day: April 14, 2026

EvolveImmune Therapeutics to Present Update on Lead Asset EVOLVE104 and New Data for EVOLVE T Cell Engager Platform at 2026 AACR Annual Meeting

Poster Presentation to Spotlight Ongoing Phase 1 Clinical Trial of EVOLVE104 Oral and Poster Presentations to Highlight Preclinical Data Demonstrating...

Trained Therapeutix Discovery’s Chief Scientific Officer, Dr. Mulder, Honored with Fellowship at the American Institute for Medical and Biological Engineering (AIMBE)

-Recognition highlights pioneering contributions to nanomedicine underpinning the company’s RIDE platformOSS, The Netherlands, April 14, 2026 (GLOBE NEWSWIRE) -- Trained...

error: Content is protected !!